
## **Trustees’ Annual Report for the period** 

**From 1/01/2021  Period start date:  To   31/12/2021 Period end date** 

**Charity name: Back to Back (Intervertebral Disc Biology and Disease Study Group)** 

## **Charity registration number: 1079089** 

## **Objectives and Activities** 

||SORP reference||
|---|---|---|
|Summary of the purposes of<br>the charity as set out in its<br>governing document|Para 1.17|The relief of sickness by the promotion of<br>research into all matters relating to the<br>intervertebral disc disease and the<br>dissemination of results of such research|
|Summary of the main<br>activities in relation to those<br>purposes for the public<br>benefit, in particular, the<br>activities, projects or services<br>identified in the accounts.|Para 1.17 and<br>1.19|As as a result of the Covid-19 pandemic, the<br>charity was inactive over the whole of 2021<br>and hence no Trustee meetings were held<br>apart from the AGM.<br>An international scientific meeting, initially<br>organised for April 2020, with invited<br>speakers from outside the UK, had to be<br>cancelled again because of pandemic<br>restrictions and travel problems.  The<br>meeting is now scheduled for April 2022.<br>Research was hindered by closure of<br>research laboratories over much of 2021 and<br>otherwise hindered by social distancing<br>restrictions. Only one research support grant<br>application was received viz.  A request for<br>funding of £14337 to support a grant entitled<br>_A pilot study to determine if analysis of MRI,_<br>_serum and urine biomarkers can be used to_<br>_aid stratification of low back pain patients'_<br>from Prof Fairbank and Prof Taylor,<br>University of Oxford. In order to avoid<br>conflict of interest and as agreed when<br>setting up details of the B2B grant award<br>scheme, none of the referees of this grant<br>were from the home institution of the<br>applicants, viz. Oxford in this case.  In<br>accordance with recommendations from<br>referees, the grant  was awarded.  Research<br>started in October 2021.|
|Statement confirming<br>whether the trustees have<br>had regard to the guidance<br>issued by the Charity<br>Commission onpublic|Para 1.18|The trustees of Back to Back have had<br>regard to the Guidance of the Charity<br>Commission on public benefit in noting the<br>purpose of the charity is to work towards<br>understandingand treatingthe enormous|





benefit problem of low back pain affecting a large proportion (80%) of the population at some time, and ending in chronic disability for around 10% of sufferers. 

## **Additional information (optional)** 

You may choose to include further statements where relevant about: 

||SORP reference||
|---|---|---|
|Policy on grant making|Para 1.38|Thanks to the generous grant from MAPI,<br>Back to Back is now able to award funds for<br>research support into work that fosters its<br>aims.  Applications are invited from those<br>based at UK Universities or research<br>organisations and are advertised on social<br>media and through relevant scientific<br>societies.  Applications are refereed by<br>scientists and clinicians with relevant<br>expertise, and administered by the host<br>institution of the successful applicants.|
|Policy on social investment<br>including program related<br>investment|Para 1.38||
|Contribution made by<br>volunteers|Para 1.38||
|Other|||



## **Achievements and Performance** 

SORP reference 



||Summary of the main<br>achievements of the charity,<br>identifying the difference the<br>charity’s work has made to<br>the circumstances of its<br>beneficiaries and any wider<br>benefits to society as a<br>whole.|Para 1.20|Over the years, by holding small informal<br>discussion meetings on work in progress,<br>Back to Back had fostered research into the<br>biology and pathology of the intervertebral<br>disc.  The meetings have been particularly<br>helpful for young scientists, by enabling<br>them to present and discuss their research<br>work informally in a friendly, non-competitive<br>environment, and have lead to many<br>collaborations which have significantly<br>furthered knowledge in this neglected field.|
|---|---|---|---|



## **Additional information (optional)** 

You may choose to include further statements where relevant about: 

|Achievements against<br>objectives set|Para 1.41||
|---|---|---|
|Performance of fundraising<br>activities against objectives<br>set|Para 1.41||
|Investment performance<br>against objectives|Para 1.41||
|Other|||



## **Financial Review** 

|**Financial Review**|||
|---|---|---|
|Review of the charity’s<br>financial position at the end<br>of theperiod|Para 1.21|At  31.12.2021 the charity had a balance of<br>£104,526.60 in the bank|
|Statement explaining the<br>policy for holding reserves<br>stating why they are held|Para 1.22|The charity holds funds in reserve to pay for<br>at least two large future meetings.  The<br>remainder of its funds will go to supporting<br>small informal meetings and grants.|
|Amount of reserves held|Para 1.22|**£20,000**|
|Reasons for holding zero<br>reserves|Para 1.22|**N/A**|
|Details of fund materiallyin|Para 1.24|**N/A**|





|deficit|||
|---|---|---|
|Explanation of any<br>uncertainties about the<br>charity continuing as a going<br>concern|Para 1.23|**None**|



## **Additional information (optional)** 

You may choose to include further statements where relevant about: 

|The charity’s principal<br>sources of funds (including<br>any fundraising)|Para 1.47|The principal source of funding is from MAPI<br>organisation, a non-profit organization based<br>in France and dedicated to improving<br>patients' quality of life by facilitating access to<br>Patient-centred Outcome (PCO).  Fees from<br>licencing the Oswestry Disability Index (ODI),<br>widely used for assessing function and<br>quality of life in patients with low back pain,<br>are now directed to Back to Back, where they<br>will be used to fund research projects and<br>scientific meetings.|
|---|---|---|
|Investment policy and<br>objectives including any<br>social investment policy<br>adopted|Para 1.46||
|A description of the principal<br>risks facing the charity|Para 1.46|The pandemic was an unexpected risk, and<br>completely halted the major activity of Back<br>to Back, viz. holding scientific meetings.<br>Otherwise, the charity has no financial risks;<br>grants are awarded and meetings held<br>accordingto funds available.|
|Other|||





## **Structure, Governance and Management** 

|Description of charity’s<br>trusts:|||
|---|---|---|
|Type of governing document<br>(trust deed, royal charter)|Para 1.25|**A constitution**|
|How is the charity<br>constituted?<br>(e.g unincorporated<br>association, CIO)|Para 1.25|**Unincorporated association**|
|Trustee selection methods<br>including details of any<br>constitutional provisions e.g.<br>election to post or name of<br>any person or body entitled<br>to appoint one or more<br>trustees|Para 1.25|**Trustees are selected by personal**<br>**recommendation.**|



## **Additional information (optional)** 

You may choose to include further statements where relevant about: 

|Policies and procedures<br>adopted for the induction and<br>training of trustees|Para 1.51||
|---|---|---|
|The charity’s organisational<br>structure and any wider<br>network with which the<br>charity works|Para 1.51||
|Relationship with any related<br>parties|Para 1.51||
|Other|||



## **Reference and Administrative details** 

|Charity name|Back to Back (**Intervertebral Disc Biology and Disease**<br>**Study Group)**|
|---|---|
|Other name the charityuses|B2B|
|Registered charitynumber|**1079089**|
|Charity’s principal address|B2B Secretary, 3 Squitchey Lane, Oxford OX2 7LB.|
|||





**Names of the charity trustees who manage the charity** 

|1<br>2<br>3<br>4<br>5<br>6<br>7<br>8<br>9<br>10<br>11<br>12<br>13<br>14<br>15<br>16<br>17<br>18<br>19<br>20|**Trustee name**|**Trustee name**|**Office (if any)**|**Dates acted if not for whole**<br>**year **|**Name of person (or body) entitled**<br>**to appoint trustee (ifany)**|
|---|---|---|---|---|---|
||Prof Jeremy<br>Fairbank|Chairman||||
||Prof SallyRoberts|Treasurer||||
||Dr Jocelyn Urban|Secretary||||
||Prof Victor Duance|||||
||Dr Neil Eisenstein|||||
||Dr Judith Meakin|||||
||Prof Valerie<br>Sparkes|||||
||Prof Peter Winlove|||||
|||||||
|||||||
|||||||
|||||||
|||||||
|||||||
|||||||
|||||||
|||||||
|||||||
|||||||
|||||||



– Corporate trustees names of the directors at the date the report was approved 

**Director name N/A** 

Name of trustees holding title to property belonging to the charity 

|**Trustee name**|**Dates acted if not for wholeyear**||
|---|---|---|
|**N/A**|||
||||
||||
||||
||||
||||





|**Funds held as custodian trustees on behalf of others**|**Funds held as custodian trustees on behalf of others**|
|---|---|
|Description of the assets<br>held in this capacity|None|
|Name and objects of the<br>charity on whose behalf the<br>assets are held and how this<br>falls within the custodian<br>charity’s objects|N/A|
|Details of arrangements for<br>safe custody and<br>segregation of such assets<br>from the charity’s own assets|N/A|



## **Additional information (optional)** 

## **Names and addresses of advisers (Optional information)** 

|**Type of**|**Name**|**Address**|
|---|---|---|
|**adviser**|||



## **Name of chief executive or names of senior staff members (Optional information)** 

N/A 

## **Exemptions from disclosure** 

Reason for non-disclosure of key personnel details 

## **N/A** 

## **Other optional information** 



## **Declarations** 

**The trustees declare that they have approved the trustees’ report above.** 

**Signed on behalf of the charity’s trustees** 

|**Signature(s)**<br>**Full name(s)**<br>**Position (eg Secretary,**<br>**Chair, etc)**<br>**Date**|||
|---|---|---|
||Jocelyn Urban||
||<br> <br>Secretary||
||28thOctober, 2022||
||28thOctober, 2022||






**Charity Name No (if any) BACK TO BACK 1079089** 

## **Receipts and payments accounts** 

**For the period** Period start date Period end date **To from** 01/01/21 31/12/21 

## **Section A Receipts and payments** 

|**Section A Receipts and payments**|**Section A Receipts and payments**||||
|---|---|---|---|---|
|**Unrestricted**<br>**funds**<br>**to the nearest      £**<br>**A1 Receipts**<br>Interest on bank accounts<br>**2**<br>Donations<br>**50**<br>ODI royalties from MAPI trust<br>**45,887**<br>Gift aid from HMRC<br>**5,550**<br>**-**<br>**-**<br>**-**<br>**-**<br>**_Sub total_**_(Gross income for AR)_**51,489**<br>**A2 Asset and investment sales,**<br>**(see table).**<br>**-**<br>**-**<br>**_Sub total_                                 -**<br>**_Total receipts_                     51,489**<br>**A3 Payments**<br>Meetingexpenses<br>**-**<br>Researchgrantpayments<br>**-**<br>Unpresented cheques from 2019<br>**-**<br>Donation to British Heart Foundation<br>**100**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**_Sub total_                             100**<br>**A4 Asset and investment**<br>**purchases, (see table)**<br>**-**<br>**-**<br>**_Sub total_                                  -**<br>**_Total payments_                          100**<br>**_Net of receipts/(payments)_                     51,389**<br>**A5 Transfers between funds**<br> **-**<br>**A6 Cash funds last year end**<br>**53,138**<br>**_Cash funds this year end_                   104,527**||**Restricted funds**<br>**to the nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br> **-   **<br>**-**<br>**-**|**Endowment**<br>**funds**<br>**to the nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br> **-**<br>**-**<br>**-**|**Total funds**<br>**to the nearest £**|
|||||**2**|
|||||**50**|
|||||**45,887**|
|||||**5,550**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**51,489**|
||||||
|||||**-**|
|||||**-**|
|||||**-**|
||||||
|||||**51,489**|
||||||
|||||**-**|
|||||**-**|
|||||**-**|
|||||**100**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**100**|
||||||
|**A4 Asset and investment**<br>**purchases, (see table)**|||||
||**-**|||**-**|
||**-**|||**-**|
|**_Sub total_ **|**-**|||**-**|
|**_Total payments_ **<br>**_Net of receipts/(payments)_ **<br>**A5 Transfers between funds**<br>**A6 Cash funds last year end**<br>**_Cash funds this year end_ **|||||
|||||**100**|
||||||
||**51,389**|**-**|**-**|**51,389**|
||**-**|**- **|**-**|**-**|
||**53,138**|**-**|**-**|**53,138**|
||**104,527**|**-**|**-**|**104,527**|



CCXX R1 accounts (SS) 

30/10/22 

1 



## **Section B Statement of assets and liabilities at the end of the period** 

||||||||**Unrestricted**||||||**Restricted funds**|**Restricted funds**|||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|**Categories**||**Details**|||||**funds**||||||||||
||||||||**to nearest £**|||||||**to nearest £**|||
|**B1 Cash funds**||Coop current account|||||**104,527**|||||||**-**|||
||||||||||||||||||
||||||||**-**|||||||**-**|||
||||||||||||||||||
||||||||**-**|||||||**-**|||
||||**_Total cash funds_**||||**104,527**|||||||**-**|||
|||(agree balances with receipts and payments|||||||||||||||
||||account(s))|||OK||||||OK|||||
||||||||**Unrestricted**||||||**Restricted funds**||||
||||||||**funds**||||||||||
||**Details**||||||**to nearest £**|||||||**to nearest £**|||
|**B2 Other monetary assets**|||||||**-**|||||||**-**|||
||||||||||||||||||
||||||||**-**|||||||**-**|||
||||||||||||||||||
||||||||**-**|||||||**-**|||
||||||||||||||||||
||||||||**-**|||||||**-**|||
||||||||||||||||||
||||||||**-**|||||||**-**|||
||||||||||||||||||
||||||||**-**|||||||**-**|||
||||||||||||||||||
||**Details**||||||**Fund to which asset**<br>**belongs**||||||**Cost (optional)**||||
|**B3 Investment assets**||||||||||||||**-**|||
||||||||||||||||||
|||||||||||||||**-**|||
||||||||||||||||||
|||||||||||||||**-**|||
||||||||||||||||||
|||||||||||||||**-**|||
||||||||||||||||||
|||||||||||||||**-**|||
||||||||||||||||||
||**Details**||||||**Fund to which asset**<br>**belongs**||||||**Cost (optional)**||||
|**B4 Assets retained for the**||||||||||||||**-**|||
|**charity’s own use**||||||||||||||**-**|||
||||||||||||||||||
|||||||||||||||**-**|||
||||||||||||||||||
|||||||||||||||**-**|||
||||||||||||||||||
|||||||||||||||**-**|||
||||||||||||||||||
|||||||||||||||**-**|||
||||||||||||||||||
|||||||||||||||**-**|||
||||||||||||||||||
|||||||||||||||**-**|||
||||||||||||||||||
|||||||||||||||**-**|||
||||||||||||||||||
||||||||**Fund to which**|||||||**Amount due**|||
||**Details**||||||**liability relates**|||||||**(optional)**|||
|**B5 Liabilities**||Research support ref: 2021 Fairbank||||||||||**-**||**14,337**|||
||||||||||||||||||
|||||||||||||||**-**|||
||||||||||||||||||
|||||||||||||||**-**|||
||||||||||||||||||
|||||||||||||||**-**|||
||||||||||||||||||
|||||||||||||||**-**|||
||||||||||||||||||
|Signed by one or two trustees on behalf<br>of all the trustees|||Signature||||Print|||Name|||||||
||||||||Judith R.|||||Meakin|||||
||||||||||||||||||
||||||||||||||||||



CCXX R2 accounts (SS) 

30/10/22 

2 




**----- Start of picture text -----**<br>
CC16a<br>**----- End of picture text -----**<br>


**Last year to the nearest £** 


**----- Start of picture text -----**<br>
                            34<br>                            50<br>                     29,158<br>                             -<br>                             -<br>                             -<br>                             -<br>                             -<br>                     29,243<br>**----- End of picture text -----**<br>


**-** 

**29,243** 


**----- Start of picture text -----**<br>
                            84<br>                     10,043<br>                       2,639<br>                             -<br>                             -<br>                             -<br>                             -<br>                             -<br>                             -<br>                     12,766<br>**----- End of picture text -----**<br>


**12,766 16,476 - 36,661 53,138** 

CCXX R3 accounts (SS) 

30/10/22 

3 



## **Endowment funds to nearest £** 


**----- Start of picture text -----**<br>
OK<br>Endowment<br>funds<br>to nearest £<br>**----- End of picture text -----**<br>



**----- Start of picture text -----**<br>
                             -<br>                             -<br>                             -<br>                             -<br>                             -<br>                             -<br>**----- End of picture text -----**<br>



**----- Start of picture text -----**<br>
Current value<br>(optional)<br>                             -<br>                             -<br>                             -<br>                             -<br>                             -<br>**----- End of picture text -----**<br>



**----- Start of picture text -----**<br>
Current value<br>(optional)<br>**----- End of picture text -----**<br>



**----- Start of picture text -----**<br>
When due<br>(optional)<br>2022-2023<br>**----- End of picture text -----**<br>


Date of approval 

06-Sep-22 

CCXX R4 accounts (SS) 

30/10/22 

4 



## **To the Trustees of Back to Back (Intervertebral Disc Biology and Disease Study Group) Charity No. 1079089** 

I report to the trustees of Back to Back (Intervertebral Disc Biology and Disease Study Group) on my examination of the accounts of the charity for the year ended 31[st] December, 2021. 

## **Respective responsibilities and basis of report** 

As the charity trustees you are responsible for the preparation of the financial statements in accordance with the Charities Act 2011 (the 2011 Act). 

I report in respect of my examination of the Charity’s accounts carried out under Section 145 of the 2011 Act; and in carrying out my examination I have followed the applicable Directions given by the Charity Commissioners under Section 145 (5) (b) of the Act. 

## **Independent Examiner’s Statement** 

I have completed my examination. I confirm that no material matters have come to my attention in connection with the examination which gives me cause to believe that in any material respect: 

- accounting records were not kept in accordance with section 130 of the 2011 

- Act; or 

- the accounts did not accord with the accounting records. 

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in order to enable a proper understanding of the accounts to be reached. 


Signed: 

Date  26th October, 2022 

John Robert Eke Fellow of the Association of Charity Independent Examiners Soarview 4 Stable Court Malborough, Devon, TQ7 3FB 

